Nuvation Bio (NUVB) News Today $2.20 -0.07 (-2.86%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$2.26 +0.05 (+2.49%) As of 02/21/2025 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law FirmFebruary 18, 2025 | prnewswire.comNuvation Bio Inc. (NYSE:NUVB) Short Interest Up 14.3% in JanuaryNuvation Bio Inc. (NYSE:NUVB - Get Free Report) saw a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 25,210,000 shares, a growth of 14.3% from the January 15th total of 22,050,000 shares. Currently, 11.0% of the shares of the stock are short sold. Based on an average trading volume of 2,590,000 shares, the days-to-cover ratio is currently 9.7 days.February 17, 2025 | marketbeat.comNuvation Bio: Pending Approval Shot In ROSL+ NSCLS Looks A Major Upside CatalystFebruary 13, 2025 | seekingalpha.comPeapod Lane Capital LLC Invests $1.04 Million in Nuvation Bio Inc. (NYSE:NUVB)Peapod Lane Capital LLC acquired a new stake in shares of Nuvation Bio Inc. (NYSE:NUVB - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 391,745 shares of the company'February 13, 2025 | marketbeat.comNuvation Bio executive departs after key milestonesFebruary 12, 2025 | msn.comKuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law FirmFebruary 12, 2025 | investing.comNuvation Bio launches EAP for lung cancer drug taletrectinibFebruary 3, 2025 | msn.comNuvation Bio Announces Expanded Access Program in the U.S. for Taletrectinib in Advanced ROS1-positive Non-Small Cell Lung CancerFebruary 3, 2025 | finance.yahoo.comNuvation Bio begins EAP for taletrectinib in US for advanced ROS1 + NSCLCFebruary 3, 2025 | markets.businessinsider.comNuvation Bio Announces Expanded Access Program in the U.S. ...February 3, 2025 | gurufocus.comWith 46% stake, Nuvation Bio Inc. (NYSE:NUVB) seems to have captured institutional investors' interestJanuary 30, 2025 | finance.yahoo.comHC Wainwright Cuts Earnings Estimates for Nuvation BioNuvation Bio Inc. (NYSE:NUVB - Free Report) - Equities research analysts at HC Wainwright dropped their Q3 2025 earnings estimates for Nuvation Bio in a report issued on Thursday, January 23rd. HC Wainwright analyst R. Burns now anticipates that the company will earn ($0.16) per share for the quaJanuary 27, 2025 | marketbeat.comAssenagon Asset Management S.A. Sells 309,176 Shares of Nuvation Bio Inc. (NYSE:NUVB)Assenagon Asset Management S.A. lessened its stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 70.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 129,363 shares of the company's stock after selling 309,176 shares during the perioJanuary 26, 2025 | marketbeat.comJPMorgan Chase & Co. Increases Position in Nuvation Bio Inc. (NYSE:NUVB)JPMorgan Chase & Co. boosted its holdings in shares of Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 479.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 442,913 shares of the company's stock after pJanuary 26, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Trading Down 3.8% - Here's WhyNuvation Bio (NYSE:NUVB) Trading Down 3.8% - Here's WhyJanuary 24, 2025 | marketbeat.comNuvation Bio price target raised to $11 from $10 at H.C. WainwrightJanuary 24, 2025 | markets.businessinsider.comNuvation Bio (NYSE:NUVB) Given New $11.00 Price Target at HC WainwrightHC Wainwright increased their price objective on Nuvation Bio from $10.00 to $11.00 and gave the company a "buy" rating in a report on Thursday.January 23, 2025 | marketbeat.comNuvation Bio Inc. (NYSE:NUVB) Short Interest UpdateNuvation Bio Inc. (NYSE:NUVB - Get Free Report) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 20,940,000 shares, an increase of 35.9% from the December 15th total of 15,410,000 shares. Approximately 9.1% of the company's shares are sold short. Based on an average daily trading volume, of 2,320,000 shares, the short-interest ratio is currently 9.0 days.January 16, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Stock Price Down 5.6% - Time to Sell?Nuvation Bio (NYSE:NUVB) Stock Price Down 5.6% - Here's WhyJanuary 14, 2025 | marketbeat.comJane Street Group LLC Decreases Stake in Nuvation Bio Inc. (NYSE:NUVB)Jane Street Group LLC decreased its position in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 71.7% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 84,039 shares of the company's stock after selling 213,290 shares during the quarter. JaJanuary 13, 2025 | marketbeat.comNuvation Bio FY2024 EPS Estimate Increased by HC WainwrightNuvation Bio Inc. (NYSE:NUVB - Free Report) - Equities research analysts at HC Wainwright raised their FY2024 EPS estimates for Nuvation Bio in a report issued on Monday, January 6th. HC Wainwright analyst R. Burns now expects that the company will earn ($0.37) per share for the year, up from theJanuary 9, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Stock Price Down 8.3% - Here's WhyNuvation Bio (NYSE:NUVB) Stock Price Down 8.3% - Time to Sell?January 8, 2025 | marketbeat.comRBC Capital Remains a Buy on Nuvation Bio (NUVB)January 8, 2025 | markets.businessinsider.comNuvation Bio price target raised to $10 from $6 at RBC CapitalJanuary 8, 2025 | markets.businessinsider.comNuvation Bio (NYSE:NUVB) Shares Gap Up - Here's What HappenedNuvation Bio (NYSE:NUVB) Shares Gap Up - Here's WhyJanuary 7, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Receives "Outperform" Rating from Royal Bank of CanadaRoyal Bank of Canada restated an "outperform" rating and set a $10.00 target price (up from $6.00) on shares of Nuvation Bio in a report on Tuesday.January 7, 2025 | marketbeat.comNuvation Bio to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 7, 2025 | finance.yahoo.comNuvation Bio's (NUVB) "Outperform" Rating Reiterated at WedbushWedbush reaffirmed an "outperform" rating and set a $5.00 price target on shares of Nuvation Bio in a research note on Monday.January 6, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Given Buy Rating at HC WainwrightHC Wainwright reissued a "buy" rating and set a $7.00 target price on shares of Nuvation Bio in a research report on Monday.January 6, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Trading Up 10% - Time to Buy?Nuvation Bio (NYSE:NUVB) Stock Price Up 10% - What's Next?January 3, 2025 | marketbeat.comInnovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products AdministrationJanuary 2, 2025 | prnewswire.comGeode Capital Management LLC Boosts Holdings in Nuvation Bio Inc. (NYSE:NUVB)Geode Capital Management LLC boosted its stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 5.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,028,692 shares of the company's stock after acquirinJanuary 2, 2025 | marketbeat.comWhy Is Nuvation Bio (NUVB) the Best Biotech Penny Stock to Invest in Now?December 31, 2024 | msn.comNuvation Bio Inc. (NYSE:NUVB) Stock Position Raised by State Street CorpState Street Corp increased its position in shares of Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 4.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,166,441 shares of the company's stock after acquiringDecember 27, 2024 | marketbeat.comFDA accepts Nuvation Bio’s NDA for taletrectinib to treat ROS1+NSCLCDecember 25, 2024 | markets.businessinsider.comNuvation Bio's NDA For Taletrectinib Gets FDA Priority Review, Stock Up In Pre-MarketDecember 23, 2024 | markets.businessinsider.comFDA accepts Nuvation Bio's application for taletrectinibDecember 23, 2024 | msn.comWedbush Reaffirms "Outperform" Rating for Nuvation Bio (NYSE:NUVB)Wedbush restated an "outperform" rating and issued a $5.00 price target on shares of Nuvation Bio in a research report on Monday.December 23, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Gap Up - Time to Buy?Nuvation Bio (NYSE:NUVB) Shares Gap Up - Time to Buy?December 23, 2024 | marketbeat.comInnovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products AdministrationDecember 20, 2024 | prnewswire.comNuvation Bio Inc. (NYSE:NUVB) Shares Purchased by Wellington Management Group LLPWellington Management Group LLP raised its stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 83.3% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 623,973 shares of the company's stock after purchasing an additional 283,642 shares during the period. WellinDecember 20, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Trading Up 5% - Time to Buy?Nuvation Bio (NYSE:NUVB) Trading 5% Higher - Time to Buy?December 19, 2024 | marketbeat.comPoint72 Asset Management L.P. Invests $634,000 in Nuvation Bio Inc. (NYSE:NUVB)Point72 Asset Management L.P. purchased a new stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 276,714 shares of the company's stock, valued at approxDecember 12, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Makes New $2.79 Million Investment in Nuvation Bio Inc. (NYSE:NUVB)Frazier Life Sciences Management L.P. acquired a new stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 1,218,236 shares of the company's stock, valued at approximately $2,790,000. Frazier LDecember 10, 2024 | marketbeat.comFmr LLC Buys 416,932 Shares of Nuvation Bio Inc. (NYSE:NUVB)Fmr LLC boosted its stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 1.4% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 29,238,871 shares of the company's stock after acquiring an additional 416,932 shares during the period. Fmr LDecember 7, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Gap Down - Here's WhyNuvation Bio (NYSE:NUVB) Shares Gap Down - Here's WhyDecember 6, 2024 | marketbeat.comWexford Capital LP Has $1.49 Million Position in Nuvation Bio Inc. (NYSE:NUVB)Wexford Capital LP increased its position in shares of Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 930.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 651,767 shares of the company's stock after acquiriDecember 6, 2024 | marketbeat.comNuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx ConferenceNovember 26, 2024 | finance.yahoo.comNuvation Bio’s Q3 2024 Highlights and Future ProspectsNovember 21, 2024 | markets.businessinsider.comNuvation Bio (NYSE:NUVB) Shares Down 7.7% - Time to Sell?Nuvation Bio (NYSE:NUVB) Trading Down 7.7% - Should You Sell?November 15, 2024 | marketbeat.com Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address NUVB Media Mentions By Week NUVB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NUVB News Sentiment▼0.970.60▲Average Medical News Sentiment NUVB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NUVB Articles This Week▼23▲NUVB Articles Average Week Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Xenon Pharmaceuticals News MorphoSys News Twist Bioscience News Vericel News Catalyst Pharmaceuticals News MoonLake Immunotherapeutics News Merus News Beam Therapeutics News ImmunityBio News Arrowhead Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NUVB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvation Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NUVB Stock Alerts